GENENTECH USA, INC.

CA

Biotechnology company

Active 2021–2026. The register lists this client once for every firm that files on its behalf; all 4 of its records are shown together here.

Filings
47
Filed By
4
Reported In-House
—
Reported By Firms
$1,910,000

Filings

YearFirmPeriodAmountDoc
2026 AVENUE SOLUTIONS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2026 MILLER STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
—
2026 AVENUE SOLUTIONS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$50,000
2026 MILLER STRATEGIES, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$40,000
2026 AVENUE SOLUTIONS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$50,000
2026 MILLER STRATEGIES, LLC 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$40,000
2025 AVENUE SOLUTIONS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$50,000
2025 MILLER STRATEGIES, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$80,000
2025 AVENUE SOLUTIONS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$50,000
2025 MILLER STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$110,000
Page 1 of 5  ·  47 filings Next
Filed By
FirmFilingsAmount
AVENUE SOLUTIONS 24 $1,180,000
MILLER STRATEGIES, LLC 8 $400,000
DLA PIPER LLP (US) 7 $270,000
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8 $60,000
Issue Areas

Bills Mentioned in Filings